We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.76%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$55.6B
AUM Growth
-$1.54B
(-2.7%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
8.6%
Holding
2,396
New
159
Increased
1,068
Reduced
924
Closed
192
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$145M |
| 2 |
American Electric Power
AEP
|
+$145M |
| 3 |
AT&T
T
|
+$126M |
| 4 |
ANDV
Andeavor
ANDV
|
+$120M |
| 5 |
Tyson Foods
TSN
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$282M |
| 2 |
AET
Aetna Inc
AET
|
+$185M |
| 3 |
KeyCorp
KEY
|
+$162M |
| 4 |
EA
Electronic Arts
EA
|
+$159M |
| 5 |
Biogen
BIIB
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Technology | 14.31% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 12.3% |
| 5 | Healthcare | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Tesla
TSLA
$1.3T
| $381K | ﹤0.01% |
24,885
+10,980
| +79% | +$144K |
|
1927
Terreno Realty
TRNO
$7.49B
| $379K | ﹤0.01% |
16,143
-18,377
| -53% | -$409K |
|
|
CEB
1928
DELISTED
CEB Inc.
CEB
| $379K | ﹤0.01% |
5,859
-98,345
| -94% | -$5.63M |
|
|
CXRX
1929
DELISTED
Concordia International Corp. Common Stock
CXRX
| $377K | ﹤0.01% |
14,689
-76,986
| -84% | -$2.3M |
|
1930
Novavax
NVAX
$1.31B
| $376K | ﹤0.01% |
3,642
-6,353
| -64% | -$682K |
|
|
JAH
1931
DELISTED
JARDEN CORPORATION
JAH
| $375K | ﹤0.01% |
6,356
-170,271
| -96% | -$9.11M |
|
|
EVER
1932
DELISTED
Everbank Financial Corp
EVER
| $374K | ﹤0.01% |
24,794
-570
| -2% | -$7.92K |
|
|
DRRX
1933
DELISTED
DURECT Corp
DRRX
| $373K | ﹤0.01% |
27,642
-35,149
| -56% | -$448K |
|
|
TRST
1934
Trustco Bank Corp NY
TRST
$938M
| $371K | ﹤0.01% |
12,246
+9,731
| +387% | +$278K |
|
|
BCOV
1935
DELISTED
Brightcove, Inc.
BCOV
| $371K | ﹤0.01% |
+59,374
| New | +$344K |
|
1936
Rayonier
RYN
$6.55B
| $369K | ﹤0.01% |
16,476
-12,945
| -44% | -$252K |
|
|
BLT
1937
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $368K | ﹤0.01% |
36,867
-31,435
| -46% | -$302K |
|
1938
HCI Group
HCI
$2.41B
| $366K | ﹤0.01% |
10,977
-8,365
| -43% | -$272K |
|
|
PARA
1939
DELISTED
Paramount Global Class B
PARA
| $365K | ﹤0.01% |
6,625
-513,999
| -99% | -$25M |
|
1940
Xencor
XNCR
$1.55B
| $364K | ﹤0.01% |
27,134
+6,285
| +30% | +$74.4K |
|
|
NBL
1941
DELISTED
Noble Energy, Inc.
NBL
| $363K | ﹤0.01% |
11,546
-66,515
| -85% | -$2.03M |
|
|
GTT
1942
DELISTED
GTT Communications, Inc.
GTT
| $361K | ﹤0.01% |
21,813
-3,805
| -15% | -$58K |
|
|
CVGW
1943
DELISTED
Calavo Growers
CVGW
| $358K | ﹤0.01% |
6,272
-205
| -3% | -$10.6K |
|
1944
Marcus & Millichap
MMI
$1.19B
| $357K | ﹤0.01% |
14,052
-16,310
| -54% | -$382K |
|
1945
Ribbon Communications
RBBN
$383M
| $357K | ﹤0.01% |
47,365
-35,479
| -43% | -$237K |
|
1946
ANI Pharmaceuticals
ANIP
$1.78B
| $356K | ﹤0.01% |
10,568
-2,120
| -17% | -$71.9K |
|
1947
Tenaris
TS
$26.8B
| $355K | ﹤0.01% |
14,322
-584
| -4% | -$12.8K |
|
|
KITE
1948
DELISTED
Kite Pharma, Inc.
KITE
| $355K | ﹤0.01% |
7,740
-23,916
| -76% | -$1.16M |
|
1949
BioCryst Pharmaceuticals
BCRX
$2.4B
| $353K | ﹤0.01% |
124,614
+100,050
| +407% | +$443K |
|
|
CALA
1950
DELISTED
Calithera Biosciences, Inc
CALA
| $352K | ﹤0.01% |
3,096
+1,878
| +154% | +$213K |
|
Similar funds
VGA
AQR Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, AQR Capital Management held 2,396 positions worth $55.6B, down 2.7% from $57.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
AQR Capital Management withdrew a net $1.96B in Q1 2016, closing 192 positions and reducing 924 holdings. Its most notable exit was Broadcom, an estimated $82.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, AQR Capital Management opened a new position in CONCHO RESOURCES INC. worth $18.5M.
- AQR Capital Management's largest Q1 2016 buy was CONCHO RESOURCES INC.: 182,889 shares worth $18.5M.
- AQR Capital Management added most to Verizon in Q1 2016, an estimated $145M increase.
- AQR Capital Management's biggest Q1 2016 reduction was Pfizer, cutting an estimated $282M.
- AQR Capital Management fully exited Broadcom in Q1 2016, selling an estimated $82.9M.
- AQR Capital Management's ten largest holdings make up 8.6% of its $55.6B portfolio in Q1 2016.
- AQR Capital Management opened 159 new positions and closed 192 in Q1 2016.
- AQR Capital Management's portfolio value fell 2.7% quarter-over-quarter to $55.6B.
Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.